Erratum to: Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney

Detalles Bibliográficos
Autores principales: Miner, Jeffrey N., Tan, Philip K., Hyndman, David, Liu, Sha, Iverson, Cory, Nanavati, Payal, Hagerty, David T., Manhard, Kimberly, Shen, Zancong, Girardet, Jean-Luc, Yeh, Li-Tain, Terkeltaub, Robert, Quart, Barry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059967/
https://www.ncbi.nlm.nih.gov/pubmed/27733209
http://dx.doi.org/10.1186/s13075-016-1150-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059967/
https://www.ncbi.nlm.nih.gov/pubmed/27733209
http://dx.doi.org/10.1186/s13075-016-1150-7

Ejemplares similares